BRK Transseptal Needles

2,600,000+

Procedures Worldwide1

With over 2.6 million procedures world wide1, the BRK™ Transseptal Needle, XS Series has demonstrated the consistency, reliability, and stability you rely on. Designed for seamless operation, all BRK Transseptal Needles integrate optimally with Abbott guiding introducers. Robust full-metal construction and user-inspired features offer quality performance, and expanded options promote procedural flexibility.

Go Transseptal Efficiently and Economically

Experience the consistency, reliability and stability of the world’s most widely used2 transseptal needle design.

Use less puncture force to penetrate3 the fossa ovalis with BRK Transseptal Needle, XS Series

A steeper angle of approach with two curve styles: the standard BRK Transseptal Needle, XS Series curve or the BRK-1™ Transseptal Needles, XS Series curve

Procedural accuracy with three usable lengths: 71cm, 89cm, 98cm

Bold Solutions
to Challenge AFIB

Manuals & Technical Resources

Manuals & Technical Resources

Order Cardiovascular Products

Cardiovascular Products

Customer Service

Customer Service

References

  1. Abbott internal data on file PULSE data.
  2. MRG Regional Medtech 360 Reports: Electrophysiology Mapping and Ablation Devices, 2018-2021
  3. 90133174 - BRK Puncture Force Specification Technical Report

MAT-2301804 v1.0

Indications, Safety & Warnings

BRK™ and BRK™ XS
Transseptal Needles

Indications

The BRK Transseptal Needle is used to puncture the interatrial septum during a transseptal catheterization procedure to gain left heart access.
 

Contraindications

The BRK Transseptal Needle (TSN) is contraindicated for Previous interatrial septal patch or prosthetic atrial septal defect closure device, Any previous thromboembolic event, Known or suspected left atrial myxoma, Known or suspected myocardial infarction within the last two weeks, Unstable angina, Recent cerebral vascular accident (CVA), Patients who do not tolerate anticoagulation therapy and Patients with an active infection.
 

Warnings

Do not alter this medical device in any way. Do not reuse this medical device. After use, thorough cleaning of biological and foreign material is not possible. Adverse patient reactions may result from reuse of this medical device.
 

Precautions

The clinical user of BRK TSN is cautioned that their use is restricted to sale by or on the order of a licensed physician. BRK TSNs must be stored in a cool, dark, and dry location. This device is intended for one time use only. Do not reprocess or reuse BRN TSNs. Reuse of BRK TSNs can cause patient injury. For special patient population: Prior to a surgical procedure employing a BRK TSN, the patient must be hemodynamically stable. Certain medical conditions may require special attention when using this medical device. These may include, but are not limited to the following: Rotated heart, Enlarged aortic root, Marked right atrial 0RA) enlargement, Scoliosis (a neuro-muscular condition influenced by other factors, although it appears to be a bone condition) or kyphosis (characterized by an abnormally rounded upper back), Abnormal left atrial (LA) geometry, Congenital cardiac malformations, Vascular malformations and Inability to access the right atrium (RA) via the inferior vena cava (IVC). Concerning procedural considerations: Users (physicians) of BRK TSNs should comply with the following precautions/cautions: Carefully reading the Instructions (IFU) before use of this device will help reduce the potential risks associated with the transseptal catherization technique such as embolism or cardiovascular perforation. Only those physicians who are specially trained in transseptal procedures should use this device. Fluoroscopy should be used to confirm positioning throughout the procedure. Transseptal procedures should be performed only in facilities appropriately equipped and staffed to perform such procedures. Laboratory/clinical facility capabilities should include, but are not limited to, having the following:

  • Intra-cardiac pressure monitoring capabilities.
  • Systemic pressure monitoring capabilities.
  • Contrast media injection and management of untoward reactions to contrast media.
  • Pericardiocentesis (i.e., aspiration of fluid from the pericardial space or sac that surrounds the heart).
  • Surgical backup.
  • Anticoagulation therapy and monitoring.
     

Potential Complications

Complications that may occur during use of this device include, but are not limited to:

  • Air embolism
  • Cardiac perforation
  • Cardiac tamponade
  • Conduction system disturbances such as SA node, AV node, or His-Purkinje system block
  • Hematoma or excessive bleeding at the vascular access site
  • Reaction to contrast medium
  • Stroke
  • Thromboembolism
  • Valvular damage
  • Cardiac arrhythmias

MAT-2301805 v2.0